GlassScriptPhysician profile
Abbey L Modlin
NPI 1295253557
$12,167.02
in general payments reported to CMS, 2019-2025
12 companies · $3,482 in 2025
The $3,482 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $599 · 2022: $166 · 2023: $3,311 · 2024: $4,608 · 2025: $3,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,175 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Food and Beverage: $1,485 · Consulting Fee: $500 · Travel and Lodging: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,175.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Food and Beverage | $1,485.42 |
| Consulting Fee | $500.00 |
| Travel and Lodging | $240.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,747.29 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $259.62 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $245.80 | 2021-2024 | |
| Medtronic, INC. | $233.76 | 2022-2024 | Minimed 780g |
| Insulet Corporation | $220.33 | 2024-2025 | Omnipod, Omnipod |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2023 | Farxiga |
| Tandem Diabetes Care, INC. | $121.13 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $80.64 | 2025 | |
| Amgen INC. | $68.99 | 2023 | Evenity |
| Nevro Corp. | $26.10 | 2021 | |
| Beta Bionics, INC. | $21.36 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Novo Nordisk INC | $17.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbey Modlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.